Methicillin-Resistant Staphylococcus aureus (MRSA): Competitive Landscape to 2026

Market: Pharmaceuticals and Healthcare

Global, 49 pages report, published by GlobalData

Report ThumbnailMarch-2018
Methicillin-Resistant Staphylococcus aureus (MRSA): Competitive Landscape to 2026

Summary

Methicillin-resistant Staphylococcus aureus (MRSA) is a widespread Gram-positive bacterium spread through direct contact with infected individuals. It is characterized by multiple drug resistance to beta-lactam antibiotics, including methicillin, penicillin, and oxacillin.

This report provides an assessment of the pipeline, clinical, and commercial landscape of MRSA. Overall, GlobalData expects new drug

Read More
  • Table of Contents
  • 1. Preface 2
  • 1.1 Table of Contents 2
  • 1.2 Abbreviations 3
  • 1.3 Related Reports 4
  • 1.4 Upcoming Related Reports 5
  • 2. Executive Summary 6
  • 2.2 Key Findings 7
  • 2.2 Key Events 8
  • 3. Introduction 9
  • 3.1 Report Scope 10
  • 3.2 Disease Overview and Epidemiology 12
  • 4. Pipeline Assessment 14
  • 4.1 Pipeline Overview 15
  • 4.2 Pipeline Breakdown by Region/Country 17
  • 4.3 Pipeline Breakdown by Molecule Type and Target 18
  • 4.4 Drug Review Designations 19
  • 4.5 Products in Clinical Development 20
  • 5. Clinical T
Read More

Please select a license type

Share

Related Products

GlobalDataMethicillin-Resistant Staphylococcus aureus (MRSA): Competitive Landscape to 2026Product ThumbnailMethicillin-Resistant Staphylococcus aureus (MRSA): Competitive Landscape to 2026, Industry ReportProduct #: 1176067
GlobalData
TeleResearch
Global Markets Direct
GBI Research
MarketsandMarkets
MicroMarketMonitor
PayPal Acceptance Mark
SSL Certificate
Copyright © 2020 Global Market Analyst. All Rights Reserved